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Summary 
Lung disease due to nontuberculous mycobacteria (NTM) occurs with disproportionate 
frequency in postmenopausal women with a unique phenotype and without clinically 
apparent predisposing factors.  Dubbed “Lady Windermere Syndrome”, the phenotype 
includes low body mass index (BMI), tall stature, and higher than normal prevalence of 
scoliosis, pectus excavatum and mitral valve prolapse.  Although the pathomechanism for 
susceptibility to NTM lung disease in these patients remains uncertain, it is likely to be 
multifactorial.  A role for the immunomodulatory consequences of oestrogen deficiency and 
altered adipokine production has been postulated.  Altered levels of adipokines and 
dehydroepiandrosterone have been demonstrated in patients with NTM lung disease.  Case 
reports of NTM lung disease in patients with hypopituitarism support the possibility that 
altered endocrine function influences disease susceptibility.  This article catalogues the 
evidence for immunomodulatory consequences of predicted endocrine changes in Lady 
Windermere Syndrome with emphasis on the immune response to mycobacteria.  
Collectively, the data warrant further exploration of an endocrine link to disease 
susceptibility in Lady Windermere Syndrome. 
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Introduction 
Nontuberculous mycobacteria (NTM) are traditionally defined as species of the genus 
Mycobacterium that do not cause tuberculosis (TB) or leprosy.  Recent phylogenomic 
analysis has supported division of this genus into an emended genus Mycobacterium and four 
novel genera.  The species of these genera remain members of the family Mycobacteriaceae 
and the term “mycobacterial species” remains valid (1).  Additionally, “NTM” remains 
current clinical nomenclature.  Therefore, “NTM” will be used in the current review to denote 
the non-lepromatous and non-tuberculous species of the genera of Mycobacteriaceae and 
describe disease caused by these species. 
 
NTM are environmental organisms that are widely distributed in water and soil, with a 
predilection for human-engineered water systems (2).  Human infection may manifest as lung 
disease, defined by the combination of supporting clinical features; nodular bronchiectasis or 
cavitation on chest imaging; and microbiological culture positivity (3).  Although the 
incidence of NTM lung disease is increasing, this condition remains uncommon (4).  This 
disconnect between the ubiquity of NTM and the rarity of disease implicates host 
susceptibility in pathogenesis. 
 
Risk factors for NTM lung disease include pre-existing structural lung disease; genetic 
predisposition to bronchiectasis and/or pulmonary infections; and immunologic deficiencies 
(5).  Reich and Johnson reported a series of patients without clinically apparent predisposing 
factors who were predominantly elderly females with a fibronodular radiographic pattern of 
NTM disease affecting the middle lobe and lingula (6).  The authors hypothesised that 
voluntary cough suppression was contributory and offered the descriptor, “Lady 
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Windermere’s Syndrome”, to convey the fastidiousness of such behaviour.  This 
characteristic phenotype is now recognised to include tall stature, reduced BMI and increased 
frequency of connective tissue-related abnormalities such as scoliosis, pectus excavatum and 
mitral valve prolapse (7, 8). 
 
The basis for susceptibility to NTM lung disease in Lady Windermere Syndrome is yet to be 
defined.  Szymanski and colleagues conducted a candidate gene analysis that associated 
NTM lung disease with variants of immune, connective tissue, ciliary and cystic fibrosis 
transmembrane conductance regulator (CFTR) gene sets (9).  Compared to controls, patients 
had more protein-affecting variants across all categories, supporting a multigenic model of 
susceptibility.  Variants of connective tissue genes may account for physical features of Lady 
Windermere Syndrome and contribute to susceptibility (10).  For example, the fibrillin-1 
gene mutation which causes Marfan Syndrome may drive increased signalling by the 
multifunctional, immunomodulatory cytokine, transforming growth factor-beta (TGF-β) (11).  
Chan and Iseman postulated that altered adipokine production due to low fat mass or low 
circulating oestrogen due to postmenopausal status may confer susceptibility to NTM lung 
disease by modulating immune function (11).  The few studies of endocrine changes in Lady 
Windermere Syndrome have investigated leptin, adiponectin, oestrogen and the adrenal 
androgen, dehydroepiandrosterone (DHEA) (8, 12, 13).  This review explores the 
contribution of immunomodulation to Lady Windermere Syndrome with a focus on the 
capacity of these hormones to modulate the immune response to mycobacteria.  Potential 
roles for other adenohypophysial hormone systems will be considered in light of case reports 
associating NTM lung disease with panhypopituitarism (14, 15).  The hormones discussed, 
their physiological functions and predicted changes in Lady Windermere Syndrome are 
summarized in Table 1. 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
The Immune Response to Mycobacteria 
Mycobacteria are obligate intracellular organisms and the immune response to NTM (Figure 
1) has largely been elucidated through study of Mycobacterium avium complex (MAC).  
After phagocytosis by macrophages, M. avium survives within the phagosome, in part by 
inhibiting phagosome-lysosome fusion and thereby avoiding killing by lysosomal enzymes 
(16).  Phagocytosis triggers release of pro-inflammatory cytokines, including tumour necrosis 
factor-alpha (TNF-α) and interleukin-12 (IL-12) (17).  These cytokines are associated with 
the “classic” M1 phenotype of macrophage activation as opposed to the “alternative”, anti-
inflammatory M2 phenotype which is associated with secretion of TGF-β and interleukin-10 
(IL-10) (18).  TNF-α acts in an autocrine fashion to activate bacteriostatic and bactericidal 
activities of macrophages.  Bactericidal mechanisms are mediated by nitric oxide (NO), 
produced by nitric oxide synthases, and include generation of cytotoxic reactive nitrogen 
intermediates (19).  Neutrophils and natural killer (NK) cells contribute to the innate immune 
response to MAC (20, 21).  NK cell anti-mycobacterial functions include cytotoxicity 
directed against infected cells and production of immunoregulatory cytokines (22).  NK cells 
respond to TNF-α and IL-12 by releasing interferon-gamma (IFN-γ), which drives activation 
of macrophages and establishes a positive feedback loop by enhancing IL-12 production (17). 
 
The positive feedback loop involving IL-12 and IFN-γ is the cornerstone of immunity to 
mycobacteria.  Macrophages, neutrophils and other antigen-presenting cells (APCs), such as 
dendritic cells (DCs), produce IL-12 which drives the differentiation of T cells towards the 
IFN-γ-producing Th1 phenotype and enhances cytotoxic T cell (CTL) function (23, 24).  IL-
12 also enhances proliferation of human antigen-specific CD4+ and CD8+ T cells in response 
to M. avium (25).  The accumulation of mycobacteria-infected macrophages and antigen-
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specific T cells is the basis of the granuloma, the hallmark inflammatory structure of 
mycobacterial infection.  The importance of these pathways in humans is illustrated by 
conditions that result in their deficiency.  A number of inherited genetic mutations that impair 
the IL-12 – IFN-γ signalling pathway confer susceptibility to localised or disseminated NTM 
infection and are relatively specific to infection by mycobacteria (5).  HIV-infected 
individuals are susceptible to disseminated NTM infection due to failure of granulomatous 
inflammation (17). 
 
NTM infection in Lady Windermere Syndrome is localised, associated with intact 
granulomatous inflammation and occurs in the absence of susceptibility to infection by other 
organisms.  Breakdown of the core immune systems therefore seems unlikely.  It is proposed 
that subtle perturbation of the immune response by endocrine changes may contribute to 
disease susceptibility in patients with Lady Windermere Syndrome. 
 
Leptin and Adiponectin 
Leptin and adiponectin are adipokines, the former being a signaller of satiety.  Fat mass 
normally correlates positively with leptin levels and negatively with adiponectin levels (26).  
Two studies have investigated serum adipokine concentrations in patients with NTM lung 
disease.  The patients in each study were predominantly slender, postmenopausal women. 
Tasaka and colleagues, who studied Asian patients with stable lung disease and negative 
sputum cultures, demonstrated normal relationships between BMI and adipokine levels (12).  
Adiponectin levels were higher in patients than in BMI-matched control subjects.  Although 
median leptin was 30% lower in patients, this difference did not reach statistical significance.  
Both groups were characterized by very low leptin levels and a median BMI less than 
18.5kg/m
2
.  Despite BMI matching, it is possible that fat mass differed between the groups.  
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In contrast, Kartalija et al. studied a predominantly Caucasian population that included 
patients at various stages of disease with a mean BMI of 22.06kg/m
2
 (8).  Control subjects in 
this study were of significantly greater BMI and the authors controlled for this mismatch by 
correcting adipokine levels for fat mass, measured using a calliper method.  The main finding 
was that the patient group did not exhibit the normal relationships between fat mass and 
adipokine concentrations observed in the control group.  The positive correlation of leptin 
levels with fat mass was weak due to elevated leptin in patients with lower fat mass and 
reduced leptin in patients with higher fat mass. The authors hypothesised that this 
dysregulation may be a consequence of cytokine signalling in patients with a greater burden 
of inflammation. On the assumption that premorbid adipokine regulation is normal, the 
baseline adipokine milieu of Lady Windermere Syndrome is likely to be decreased leptin and 
elevated adiponectin.  The following discussion will focus on the immunomodulatory 
consequences of these changes. 
 
Mice that lack the genes for leptin (ob/ob mice) or the leptin receptor (db/db mice) are 
susceptible to mycobacterial infection but also exhibit obesity and a number of hormonal 
abnormalities that may impair immune function (27).  The lung tissue of ob/ob mice infected 
with M. abscessus (28) or M. tuberculosis (27) was found to exhibit deficient lymphocyte 
recruitment, reduced production of IFN-γ and disorganised granuloma formation.  In 
addition, mycobacterial killing was impaired.  The IFN-γ response to M. tuberculosis was 
restored by leptin replacement.  Similar abnormalities in db/db mice with pulmonary M. 
tuberculosis infection were potentially caused by abnormal chemokine response and deficient 
antigen presentation to T cells (29).  As a consequence, expression of inducible nitric oxide 
synthase (iNOS) by myeloid cells and production of IFN-γ by T cells were delayed. 
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A number of immunomodulatory mechanisms may link leptin deficiency with susceptibility 
to mycobacterial infection.  Impaired T cell proliferative responses and altered cytokine 
production have been reported in children with congenital leptin deficiency, including 
complete suppression of IFN-γ, reduction of IL-4 and IL-10 and increase of TGF-β (30).  
These abnormalities were reversible with leptin replacement.  In vitro incubation of human T 
cells with leptin is associated with increased production of IFN-γ and IL-2 but reduced 
production of IL-4 and IL-10, particularly in activated cells (31, 32).  In the presence of 
leptin, human DCs upregulate production of several cytokines, including IL-12 and TNF-α, 
downregulate production of IL-10 and thereby drive polarization of naïve T cells toward a 
Th1 phenotype (33).  Other data suggest that leptin may also facilitate the function of NK 
cells (34). 
 
 
The immunomodulatory consequences of elevated adiponectin have been difficult to define 
due to inconsistencies between studies.  Adiponectin indirectly decreases Toll-like receptor 
(TLR)-mediated IFN-γ secretion by NK cells, possibly due to direct inhibition of APC 
functions (35).  The finding that adiponectin induces pro-inflammatory responses in primary 
human macrophages was thought to represent a program of limited activation which 
desensitises cells to further pro-inflammatory stimuli (36).  Additional complexity is 
introduced by the observation that adiponectin enhances both M1 and M2 macrophage 
functions, suggesting that the outcome of adiponectin signalling in a given inflammatory 
situation may depend on the dominant macrophage phenotype (18).  Although signalling 
through adiponectin receptors expressed by human DCs (37) and T cells (38) attenuates 
cellular immunity, studies of the capacity of adiponectin-treated murine BMDCs to drive T 
cell responses have produced conflicting results (39, 40).  These discrepancies may be a 
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consequence of variation of experimental conditions such as the timing of adiponectin 
exposure, the choice of stimulating agent and the cell model studied. 
 
Perturbation of serum adipokine levels has the potential to negatively modulate innate and 
adaptive immune responses.  The sex bias of Lady Windermere Syndrome represents a 
challenge to this hypothesis as plasma levels of leptin and adiponectin are significantly 
greater in females than males (26). 
 
Oestrogens 
Oestrogens are synthesised from androgens by aromatase.  In men, this process occurs 
primarily in extra-gonadal sites, such as adipose tissue, and may generate quantities of 
oestrogen approaching those synthesised in women (41).  The dominant form of oestrogen in 
pre-menopausal women is ovarian oestradiol (E2).  After menopause, the quantitatively most 
significant oestrogen is oestrone (E1), which is primarily produced by extra-glandular 
aromatisation of adrenal androgen precursors, particularly in adipose tissue (42).  
Aromatisation is regulated by the adipokines, with leptin being stimulatory and adiponectin 
being inhibitory (41). 
 
The association of Lady Windermere Syndrome with postmenopausal status suggests a role 
for oestrogen deficiency.  Reduced aromatisation due to low fat mass and altered adipokine 
levels may compound the consequences of ovarian failure.  It has not been established 
whether patients with Lady Windermere Syndrome are particularly oestrogen deficient in 
comparison to healthy control subjects.  Danley et al. published preliminary findings that the 
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levels of oestrone and ultrasensitive oestradiol in postmenopausal women with M. avium lung 
disease are not significantly different from those in age-matched control subjects (13). 
 
Oestrogen deficiency increases susceptibility to nontuberculous mycobacterial infection in 
rodent models.  Male mice have poorer outcomes than female mice after intravenous 
infection with M. intracellulare (43).  Superior killing of mycobacteria by female peritoneal 
macrophages was thought to be the mechanism.  In a murine study of pulmonary M. avium 
infection, ovariectomy was linked to increased pulmonary bacillary burden, a finding 
reversed by in vivo E2 replacement (44).  E2 augmented in vitro macrophage NO production 
and expression of iNOS mRNA in response to IFN-γ stimulation.  It was proposed that E2 
enhanced intracellular killing by increasing generation of reactive nitrogen intermediates.  
E2-mediated upregulation of NO generation and microbial killing is supported by rodent 
models of other infections, including Leishmaniasis (45, 46). 
 
Oestrogen deficiency may lead to dysregulation of other aspects of the immune response to 
mycobacteria.  Oestrogen appears to protect premenopausal women from the inflammatory 
consequences of sepsis by a mechanism involving reduced production of TNF-α by 
neutrophils (47).  In addition, oestrogen upregulates surface annexin A1 on human 
neutrophils, producing a phenotype that is associated with reduced activation and inhibition 
of cell adhesion (48).  High concentrations of oestrogen suppress NK cell cytotoxicity but the 
effect of oestrogen deprivation is unclear.  NK cells purified from healthy premenopausal 
women exhibit a dose-dependent reduction in cytotoxicity in response to in vitro oestrogen 
exposure (49).  Although high-dose oestrogen therapy increased the proportion of NK cells in 
splenocytes from ovariectomised mice, cytotoxicity was reduced (50).  In contrast, oestrogen 
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replacement therapy increased NK cell cytotoxicity in an ovariectomised rhesus monkey 
model of menopause (51). 
 
There is considerable evidence that oestrogens modulate adaptive CD4+ T cell responses and 
cytokine production (52).  However, consolidation of these data is difficult due to variability 
of methodologies (53); the biphasic dose-dependent nature of oestrogen-mediated effects 
(54); and the tissue-specific distribution of the multiple oestrogen receptors (55).  The effects 
of oestrogen on pulmonary granulomatous inflammation have been the subject of few studies.  
Ovariectomy in rats was associated with diffuse, mature granuloma formation in response to 
heat-killed BCG whereas control animals exhibited sparse, less well-defined granulomas 
(56).  In addition, the BAL content of ovariectomised animals was characterised by reduced 
macrophages and increased neutrophils, activated T cells and IFN-γ production.  These 
differences were reversed by E2 and progesterone when administered individually or in 
combination.  The enrichment of pulmonary granulomatous inflammation in ovariectomised 
rats was validated by a more recent study (57).  These results align with a second peak in 
incidence of sarcoidosis in older women (58).  They may be consistent with evidence that 
human DCs, when matured in the presence of E2, respond to TNF-α stimulation with biased 
production of IL-10 relative to IL-12p70 and expression of CCL1, a chemokine defining Th2 
cells and regulatory T cells (Tregs) (59).  Moreover, oestradiol potentiates the suppressive 
effects of Tregs, especially at high concentrations (60). 
Oestrogen deficiency may therefore contribute to chronic mycobacterial infection by 
impairing intracellular killing whilst facilitating dysfunction of other aspects of innate and 
adaptive immunity.  Such a scenario would be consistent with Lady Windermere Syndrome, 
in which clinical and radiological changes reflect inflammatory responses but mycobacteria 
are not cleared from respiratory specimens. 
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DHEA 
DHEA and its sulphated form, DHEAS, are androgenic steroid hormones produced primarily 
by the adrenal cortex in response to adrenocorticotrophic hormone (ACTH), with small 
quantities being produced by the gonads.  Blood levels of DHEA and DHEAS are greater in 
men than women but decline markedly with ageing in both sexes (61).  The relative 
contribution of the adrenal gland to circulating DHEA/S increases after menopause due to 
ovarian functional decline.  This may render postmenopausal women more susceptible to the 
effects of impaired adrenal androgen synthesis than younger women or men (61). 
 
The work by Danley et al. demonstrated that blood levels of DHEAS are significantly 
reduced in patients with NTM lung disease at various stages of disease and treatment (13).  
There are several potential explanations for this finding.  Rifampicin, an antibiotic used to 
treat NTM lung disease, induces hepatic cytochrome P450 enzymes which metabolise steroid 
hormones (62).  In addition, cytokines produced during the inflammatory response to 
mycobacteria may influence adrenal function.  The secretion of DHEA by adrenal cell lines is 
suppressed by the supernatant of M. tuberculosis-infected peripheral blood mononuclear cells 
(PBMCs) and TGF-β has been implicated as the causative factor (63, 64).  Reduced DHEAS 
may also arise from disorders of the hypothalamic-pituitary-adrenal (HPA) axis, such as 
adrenal insufficiency (65). 
 
Reduced blood levels of DHEA or DHEAS have also been identified in patients with TB 
infection (63, 66, 67) and HIV/TB coinfection (68).  In these studies, there was 
accompanying elevation of blood cortisol concentration or cortisol/DHEA ratio.  Cortisol, an 
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adrenal glucocorticoid with potent immunosuppressive and metabolic functions, is produced 
in increased quantities during stress and healthy ageing (69).  In vitro data support the 
immunomodulatory significance of these changes.  Bozza et al. demonstrated that stimulation 
of PBMCs from TB-infected patients resulted in significantly higher IFN-γ production by 
cells from patients with above-median plasma DHEA or below-median plasma 
cortisol/DHEA ratio (67).  DHEA additionally increased antigen-driven proliferation of 
PBMCs from tuberculin-responder healthy blood donors.  A study of M. tuberculosis-
stimulated PBMCs from patients with HIV/TB coinfection associated DHEA exposure with 
increased proportion of IFN-γ-producing cells and reduced expression of FoxP3, a marker of 
Treg activity (68).   Angerami et al. studied human DCs that were stimulated with heat-killed 
M. tuberculosis in the presence or absence of DHEA or cortisol (70).  In contrast to cortisol, 
DHEA increased IL-12 production and expression of antigen-presenting proteins by DCs, 
leading to enhanced induction of antigen-specific T cell proliferation and IFN-γ production.  
DHEA has also been associated with reduced bacterial burden in human macrophage-like 
THP-1 cells via an autophagic mechanism (71). 
 
Treatment of TB-infected mice with DHEA or its derivative, androstenediol, reduced 
pulmonary bacterial counts and altered cytokine expression whilst skewing the inflammatory 
pattern from pneumonic to granulomatous inflammation (72).  Small studies of DHEA 
supplementation in ageing men and postmenopausal women have demonstrated modulation 
of immune parameters, including increased NK cell number and cytotoxicity (73, 74).  
Although DHEA supplementation may represent an opportunity for therapeutic investigation, 
further research is required to confirm reduced DHEA/S levels in Lady Windermere 
Syndrome and investigate the possibility of HPA dysfunction. 
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Other hormones of potential significance 
Case reports have described NTM lung disease in patients with panhypopituitarism who were 
receiving hormone replacement therapy with corticosteroids and thyroid hormone (14, 15).  
The hormones of the lactotrope, somatotrope and thyrotrope axes have not been investigated 
in Lady Windermere Syndrome but are likely to be altered in comparison to younger, healthy 
women.  The production of prolactin is inhibited by dopamine and stimulated by oestradiol 
(75).  Thus, basal serum concentrations of prolactin decrease in women after menopause but 
may remain stable or increase in ageing men (76).  Most of the biological effects of growth 
hormone (GH) are mediated by insulin-like growth factors (IGFs) (77).  Pituitary GH 
secretion and serum IGF-1 concentration reduce during ageing in men and women (78).  The 
thyroid hormones, triiodothyronine (T3) and thyroxine (T4), are secreted by the thyroid gland 
in response to adenohypophysial thyroid stimulating hormone (TSH).  T4 is converted to the 
more active T3 in peripheral tissues by deiodinases (79).  Although circulating T3 and T4 do 
not change during healthy ageing (76), the prevalence of thyroid dysfunction increases (80).  
The incidence of primary hypothyroidism, especially due to autoimmune thyroiditis, 
increases with age and women are more commonly afflicted than men (80).  Data support 
beneficial effects of these hormones on immune functions that are pertinent to the control of 
mycobacterial infection, especially during physiological stress and ageing. 
 
Prolactin is produced by human PBMCs and functions in an autocrine fashion to stimulate 
lymphoproliferation (81).  Effects of prolactin on other cell types include upregulation of 
murine macrophage phagocytosis and NO generation (82, 83) and human NK cell 
cytotoxicity and IFN-γ secretion (84, 85).  Treatment of mice with bromocriptine, a dopamine 
receptor agonist, decreased production of IFN-γ from T cells and impaired activity of 
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macrophages against Listeria monocytogenes and M. bovis (86).  Replacement of prolactin 
reversed these effects.  Dorshkind and Horseman (87) argued that, rather than being 
necessary for normal immune function, the role of prolactin is to mitigate the 
immunosuppressive effects of glucocorticoids during physiological stress.  In physiological 
or stress-induced concentrations, prolactin enhances IL-12 and IFN-γ production by 
PHA+LPS-stimulated whole blood from healthy human donors and opposes the effects of 
cortisol (88).  It may be that any immunomodulatory consequences of postmenopausal 
prolactin deficiency adopt particular significance in Lady Windermere patients, who are 
subject to physiological stress driven by infection and low BMI. 
 
GH deficiency in adults and children has been associated with reductions in NK cell number, 
NK activity and the phagocytic activity of monocytes and neutrophils (78, 89).  In vitro 
studies have demonstrated that GH and IGF-1 facilitate a number of innate and adaptive 
immune functions.  IGF-1 enhances the activity of NK cells from both GH-deficient adults 
and healthy individuals (90).  GH upregulates the production of NO and TNF-α by murine 
peritoneal macrophages (83) and IGF-1 stimulates production of TNF-α by human monocytes 
(91).  In addition, GH acts via an autocrine or paracrine mechanism to enhance production of 
IFN-γ by human PBMCs stimulated with IL-12 (92).  GH treatment reverses ageing-related 
reductions of leukocyte chemotaxis, mitogen-induced lymphoproliferation and NK cell 
activity in male (93) and female (94) rats with particularly marked effect in ovariectomised 
animals. 
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Thyroid hormones exert modulatory effects on lymphocytes, macrophages and neutrophils 
(95).  Recent work has demonstrated that expression of deiodinase 2 is upregulated in murine 
macrophages during inflammation and that macrophage function is impaired in its absence, 
implying a role for locally-produced T3 (96).  Application of T3 to differentiated murine 
macrophages inhibits M2 activation but enhances M1 activation, increasing IFN-γ and TNF-α 
production and the extent of phagocytosis (97).  Murine DCs express thyroid receptors and 
T3 stimulates maturation marker expression, secretion of IL-12 and ability to drive naïve T 
cell proliferation and IFN-γ production (98).  Thyroid hormone supplementation restored 
mitogen-induced T-cell proliferation in mice subjected to chronic mild stress (99).  In elderly 
humans, NK cell activity positively correlates with serum T3 concentration (100).  In vitro T3 
supplementation significantly increased the activity of NK cells from individuals with a 
serum T3 concentration at the lower end of the reference range. 
 
The hormones of the lactotrope, somatotrope and thyrotrope axes merit investigation in Lady 
Windermere Syndrome.  Given the advanced age of Lady Windermere patients, it seems 
plausible that pathogenesis may be facilitated by immunomodulatory consequences of 
senescence or dysfunction of these systems. 
 
Discussion & Conclusion 
Elucidation of the factors that confer susceptibility to NTM lung disease in Lady Windermere 
Syndrome is a strategic priority due to the increasing incidence and challenging management 
of this condition.  We hypothesise that underlying genetic susceptibility is unmasked by 
immunomodulatory consequences of physiologic endocrine changes arising from ageing, 
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menopause or slender body habitus (Figure 1).  These changes include reduced oestrogen, 
leptin and DHEA; and increased adiponectin and cortisol.  Reduced prolactin, relative growth 
hormone deficiency and thyroid dysfunction may be additional regulators.  Non-physiologic 
changes in hormone levels and receptor function are also possible.  For example, some genes 
associated with NTM lung disease in the study by Szymanski et al. affect endocrine systems.  
Impaired CFTR function reduces follicle-stimulating-hormone-driven oestrogen biosynthesis 
(101).  Polymorphisms of the IRF8 immune gene have been associated with autoimmune 
thyroid disease, although the implicated polymorphisms differ from those that have been 
associated with NTM lung disease (102).  Additionally, Szymanski and colleagues conducted 
an exome-wide genetic burden test that identified genes of significance involved in oestrogen 
receptor signalling and lipid metabolism (9). 
 
A caveat is that immunomodulation by hormones has largely been studied in animal models 
or in vitro environments designed for investigation of isolated hormones.  Much of this data 
is yet to be validated in vivo in humans.  Many hormonal effects are dependent on factors 
such as receptor sub-type, cell type and inflammatory milieu.  Additional complexity arises 
from non-linear concentration-response relationships; inter-dependence of endocrine systems; 
and modification or production of hormones by target tissues. 
 
Further investigation is warranted to define endocrine changes of significance in Lady 
Windermere Syndrome.  As illustrated by research on DHEA in TB, demonstration of 
causality is likely to be challenging due to the bidirectional signalling between the endocrine 
and immune systems.  Certain medical co-morbidities and medications may be additional 
sources of confounding.  For example, rifampicin alters metabolism of steroid hormones.  
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Dopamine antagonists, which are commonly used to treat antibiotic-related nausea, may alter 
serum prolactin levels (75). 
 
In conclusion, multiple interacting endocrine systems have the potential to contribute to Lady 
Windermere Syndrome by modulating immune responses to mycobacteria.  Further research 
is warranted to explore the role of endocrine changes as independent susceptibility factors 
and identify new pathways for treatment. 
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Tables 
Table 1: Physiological functions and predicted changes of hormones in Lady Windermere 
Syndrome 
Hormone Origin Physiological 
Function 
Predicted 
Change 
Mechanism of 
Change 
Leptin Adipose Satiety signalling ↓ Reduced fat mass 
Adiponectin Adipose Regulation of 
metabolic processes 
(e.g., glucose and 
fatty acid 
metabolism) 
↑ Caloric restriction 
Oestrogens Ovaries, 
peripheral 
conversion of 
androgens by 
aromatase 
Female sex steroid  ↓ Menopause 
Reduced fat mass 
DHEA Adrenal 
cortex (zona 
reticularis) 
Metabolic 
intermediate in sex 
steroid synthesis 
with multiple 
oestrogenic, 
androgenic and 
other functions 
↓ Senescence 
Cortisol Adrenal 
cortex (zona 
fasciculata) 
Immunosuppression 
and regulation of 
multiple metabolic 
functions, including 
glucose control, 
sodium and water 
balance, cell 
replication, body 
composition 
(muscle and fat 
mass) 
↑ Ageing, 
physiological stress 
Prolactin Anterior 
pituitary 
Lactation ↓ Menopause – 
oestrogen 
deficiency 
GH / IGF-1 GH: anterior 
pituitary 
IGF-1: liver 
Body composition 
(muscle and fat 
mass) 
↓ Senescence 
Thyroid 
hormones 
Thyroid Regulation of 
metabolism in 
multiple 
tissues/organs 
including brain, 
heart, 
gastrointestinal 
tract, muscle, bone 
↓ Disease/dysfunction 
Abbreviations: DHEA = dehydroepiandrosterone, GH = growth hormone, IGF-1 = insulin-
like growth factor 1 
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Figure Captions 
Figure 1: The immune response to NTM and predicted modulation by hormone changes.  
Macrophages phagocytose NTM and produce TNF-α and IL-12.  TNF-α activates 
macrophage functions in an autocrine manner and both hormones stimulate NK cells to 
produce IFN-γ.  Macrophages and other antigen-presenting cells produce IL-12, which 
facilitates lymphoproliferation and drives polarisation of CD4 cells to the Th1 phenotype.  
Th1 and CD8 cells produce IFN-γ which further activates macrophages, establishing a 
positive feedback loop with IL-12.  Predicted modulation of these processes by hormone 
changes is indicated by black (inhibitory effect) and red (enhancing effect) connecting lines. 
 
 
 
 
 
